InvestorsHub Logo
Followers 55
Posts 8673
Boards Moderated 0
Alias Born 12/01/2010

Re: None

Sunday, 01/22/2017 9:42:21 AM

Sunday, January 22, 2017 9:42:21 AM

Post# of 399451
“Following our recent announcement regarding a successful FDA meeting for our immediate release Oxycodone HCl product SequestOx™, I am now very pleased to announce these positive topline study results for an abuse-deterrent twice-daily Oxycodone,” said Nasrat Hakim, President and CEO of Elite Pharmaceuticals. “We intend to file an ANDA for this product later this year.”

Now, this is intriguing, Naz knows he has to be very careful with his words, we are waiting for the release of minutes to Elite so they can P/R a resopnse. He can't say anything about approval just yet or speculate, as it could be miss leading and not fair to a prospective buyer or partner or merger, but who ever he's talking to knows whats in the pot,
just thinking out loud....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News